Pharmacology & ToxicologybioRxiv
Preclinical and Toxicology Studies of BRD5529, a Selective Inhibitor of CARD9
T. Kottom, K. Schaefbauer, E. M. Carmona…·A. Limper
This study evaluates the safety and toxicology of BRD5529, a CARD9 inhibitor, in mice, finding no significant adverse effects at tested doses.
DOI 10.1007/s40268-022-00389-0